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doi:10.1016/j.jfma.2011.02.007Mucosa associated lymphoid tissue lymphoma (MALT lymphoma) is mostly seen in the gastroin-
testinal tract; origin from the kidney is extremely rare. Waldenstro¨m macroglobulinemia (WM)
is a clinicopathologic syndrome denoted by the presence of monoclonal gammopathy in the
serum, typically caused by lymphoproliferative disorder. Literature review did not find any
report of renal MALT lymphoma accompanied by WM. Herein, for the first time, we report
a 72 year-old female patient with a history of chronic kidney disease, presenting with solitary
renal mass; MALT lymphoma was confirmed by pathological examination. A serology study
identified the presence of WM. No manifestation of hyperviscosity syndrome was noted. Bone
marrow biopsy disclosed the concurrent systemic involvement. Her treatment response was
uneventful and the renal mass responded with regressive change in size after chemotherapy.
The renal function remained stable during follow-up. MALT lymphoma should be considered as
an underlying pathology of isolated renal mass. Furthermore, patients with MALT lymphoma
should be screened for Waldenstro¨m macroglobulinemia and hyperviscosity syndrome.
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Figure 1 CT scan showed an ill-defined homogeneous mass
over right kidney, measuring 6.4  5.6 cm. No definite
enlargement of retroperitoneal lymph node or pelvic side wall
invasion was found.
Figure 2 Histological picture of renal tissue showed fibro-
vascular tissue diffusely infiltrated by small mature lymphoid
cells.
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Marginal zone B cell lymphoma, a distinctive group of
non-Hodgkin’s lymphoma, is divided into three subtypes,
nodal, extranodal and splenic, depending on the involved
location. In general, these lymphoma subtypes have an
identical microscopic morphology. Among them, extra-
nodal marginal zone B cell lymphoma, also named as
mucosa associated lymphoid tissue (MALT) lymphoma,
accounts for about 5% of non-Hodgkin’s lymphoma, and
usually involves many anatomic sites, mostly confined to
stomach.1 MALT lymphoma of renal origin is very rare, and
only sporadic cases have been reported.2,3
Waldenstro¨m macroglobulinemia (WM) is characterized
by the presence of lymphoplasmacytic lymphoma in the
bone marrow, with the appearance of monoclonal gamm-
opathy, mostly immunoglobulin (Ig) M in the serum.4 WM
often presents with nonspecific symptoms such as weak-
ness, fatigue and weight loss. However, severe complica-
tions can be caused by WM-associated hyperviscosity
syndrome. We encountered a female patient who presented
with an incidental finding of renal mass. Pathological
examination revealed MALT lymphoma. Further work-up
revealed bone marrow involvement, and abnormal IgM
was noted in her serum. She experienced an uneventful
treatment course with chemotherapy only.
Case report
On February 2009, a routine renal echogram in a 72-year-
old female patient with a medical history of chronic kidney
disease for 5 years, found a 5.8  5.4 cm mix-echoic mass
over the right middle kidney. The patient was asymptom-
atic and physical examination showed no specific finding.
Her laboratory test was essentially normal, except for mild
elevation of serum creatinine (Cr). Her results showed:
Cr Z 1.94 mg/dL, white blood cell count Z 5800 cells/mL,
hemoglobin Z 12.2 g/dL, calcium Z 9.4 mg/dL, uric acid
8.2 Z mg/dL, lactate dehydrogenase Z 187 u/L). Urine
examination was unremarkable. Further study with
abdominal computed tomography (CT) disclosed an ill-
defined homogenous soft tissue mass, with mild enhance-
ment, measuring 6.4  5.6 cm over the right kidney (Fig. 1).
No definite enlargement of the retroperitoneal lymph node
or pelvic side wall invasion was found. CT-guided biopsy
was thus performed to obtain a pathological diagnosis.
Macroscopically, there was fibrovascular tissue diffusely
infiltrated by small mature lymphoid cells (MALT lymphoma,
Fig. 2). Microscopic examination found neoplastic cells
composed of small lymphoid cells, with round or slightly
irregular contours and abundant cytoplasm.
Immunohistochemical stain showed a positive result for
CD20, and was negative for CD5, CD10, CD15, CD30, and
CD23. Serum protein electrophoresis and immunofixation
studies found the presence of monoclonal IgM kappa para-
proteinemia. The patient’s IgA, IgG, and IgM levels were
83.9 mg/dL, 1840 mg/dL, and 569 mg/dL, respectively. The
total globulin level was 3.54 g/dL. Urine protein electro-
phoresis and immunofixation studies did not detect signifi-
cant results. A subsequent bone marrow biopsy was
performed, and a normal white blood cell count, with 10%plasmacytoid lymphocytes with CD-20 positive lymphoid
cells, was noted. She then received chemotherapy a regimen
of Leukeran and prednisolone for 8 months. No treatment-
related complications developed. Gradual regressive change
of renal mass, as evidenced by a series of CT scans, was
noted. The IgM level declined gradually to as low as
145 mg/dL. Her renal function was rather stable during the
follow-up period. Surgical interventions, such as nephrec-
tomy, were not performed.Discussion
Primary renal tumor can be benign or malignant; most solid
masses involving kidneys are malignant. Renal cell carci-
noma is responsible for 80% to 85% of all primary renal
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Renal lymphoma is rare, and is usually clinically silent.
Flank pain, weight loss, hematuria or a palpable mass are
the most common signs and symptoms. For most reported
renal MALT lymphomas, clinical features varied widely and
there was no specific presentation suggesting this rare renal
tumor.1 Although a variety of diagnostic tools for renal
tumor evaluation are available, a computed tomography
scan is the most sensitive, efficient and comprehensive
method.6 Renal lymphoma on CT scans, is typically
homogenous, minimal contrast enhanced and rarely
vascular invasive. For most of time, it is unilaterally
involved and parenchymally located, which is different
from renal cell carcinoma, transitional cell carcinoma, and
metastatic renal tumors.6,7 An image study of our patient
exhibited these typical characters on a CT scan, and
lymphoma was highly suspected prior to pathologic proof.
For solitary renal tumors, surgical resection is indicated for
definite treatment and accurate diagnosis. However, in the
elderly or those at high risk for operations, percutaneous
biopsy is also an alternative to confirm the diagnosis.8
The diagnosis of MALT lymphoma is usually made based
on morphology, immunophenotype and genetic analysis.
The morphology of MALT lymphoma is characterized with
monocytoid B cells, small lymphocytes with abundant
cytoplasm and lymphoepithelial lesions. Immunophenotype
was positive for CD19, CD20, and CD22 and negative for
CD5, CD10, and CD23.1 The renal biopsy sample of our
patient fulfilled the diagnosis of MALT lymphoma. Systemic
involvement of her MALT lymphoma was documented later,
with a positive result in a bone marrow biopsy. Garcia et al
reviewed and summarized a total of 20 cases of MALT
lymphoma involving the kidney. Half of the collected
patients had simultaneous bone marrow or other organ
involvement.2 The treatment strategy included either
nephrectomy or chemotherapy, and some patients under-
went both treatments. Another report showed a good result
in a rather short follow-up period, with all patients
receiving nephrectomy.3 There is currently no conclusive
policy for the treatment of renal MALT lymphoma. Although
the renal mass was rather large, our patient responded to
chemotherapy well as evidenced by a continuous decrease
in mass size. In our patient, renal function impairment had
been noted for years. With the renal involvement of MALT
lymphoma, renal function did not deteriorate. Contrast
medium exposure during the image study did not cause
kidney injury under prophylactic treatment and prepara-
tion. Previous studies did not provide information regarding
the long term renal outcome of patients with and without
nephrectomy.2,3 Although data of patient survival is
limited, preservation of renal function should be an
important concern in these patients.
It has been estimated that approximately 15% patients
with WM developed hyperviscosity syndrome and caused
significant morbidity and mortality.2 A literature review
found that only 10 patients with MALT lymphoma hadassociated abnormal paraproteinemia, such as WM, and
none of them was of renal origin.4,9,10 Three of these
patients had complications of hyperviscosity syndrome, and
plasmapheresis or plasma exchange was thus performed.
The prognosis of these patients was not favorable; disease
relapse was frequent, despite the combination of systemic
chemotherapy and tumor resection. There was no study to
investigate the reason why MALT lymphoma had a higher
incidence of hyperviscosity syndrome than other lymphomas.
In an uncertain period of time from disease onset to diag-
nosis, our patient did not have any clinical features related
to hyperviscosity syndrome. Although a high level of para-
proteinemia was not directly correlated with the develop-
ment of hyperviscosity syndrome, serum IgM levels of our
patient were not as high as in previous reports.4,9,10 The
clinical implication and prognostic value of the development
of WM in association with hyperviscosity syndrome in renal
MALT lymphoma, however, is not yet clear. More patient
collection and clinical studies are required to clarify this
issue.
In conclusion, for the first time, we report a patient of
renal MALT lymphoma presenting with asymptomatic soli-
tary renal mass. In addition to bone marrow involvement,
WM was detected but hyperviscosity syndrome was not
evident. The renal lymphoma demonstrated a regressive
change after systemic chemotherapy and thereby
nephrectomy was not indicated.References
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